Clinical Trial of NPI-0052 (2nd generation proteasome inhibitor) in Patients Having Advanced Malignancies with Expanded RP2D Cohorts in Lymphoma and CLL
| Autor: | Price, Timothy *, Padrik, Peeter *, Townsend, Amanda *, Mainwaring, Paul *, Catley, Lawrence *, Longenecker, Angie M. *, Cropp, Gillian *, Palladino, Michael A., Lloyd, G. Kenneth *, Spear, Matthew A., Millward, Michael * |
|---|---|
| Zdroj: | In Blood 16 November 2008 112(11):4934-4934 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|